Tag - alzheimers

 
Menu
Search
 
October 05, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

ALZHEIMERS

Japan Times
JAPAN / Science & Health
Dec 22, 2022
Japan approves blood test to detect Alzheimer’s
Japan has approved one of the world’s first blood test kits to detect signs of Alzheimer’s disease, paving way for a simpler and speedier diagnosis of the ailment for which a therapy is on the horizon.
Japan Times
BUSINESS
Nov 30, 2022
Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge
The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.
BUSINESS / Markets
Nov 29, 2022
Eisai and Biogen plunge after report of second death in Alzheimer’s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer's drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
WORLD / Science & Health / ANALYSIS
Sep 30, 2022
Eisai drug's trial success raises hope for Alzheimer's prevention
Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.
Japan Times
JAPAN / Science & Health
Sep 28, 2022
Alzheimer’s progression slowed by drug in major trial
The drug slowed cognitive decline in people with early Alzheimer's by 27% over 18 months when compared with a placebo using a common rating scale.
Japan Times
BUSINESS / Companies
Jul 6, 2022
Eisai says Alzheimer’s drug will get priority review in U.S.
Under the accelerated approval pathway, drugs can be approved based on their ability to remove amyloid, a hallmark of the disease, from the brain.
Japan Times
WORLD / Science & Health
Apr 19, 2022
Scientists question data behind an experimental Alzheimer’s drug
Studies linked to Cassava Sciences, once a stock market favorite, have been retracted or challenged by medical journals.
Japan Times
BUSINESS
Apr 9, 2022
Japan's Eisai still seeking accelerated U.S. review of Alzheimer's drug
The firm said it plans to seek a quick approval even after the Medicare health plan decided to limit coverage of medicines approved in that manner.
Japan Times
COMMENTARY / World
Mar 17, 2022
The silver lining hidden in the battle against long COVID
Long COVID-19 research could reveal clues to help fight Alzheimer's, Lyme Disease and other illnesses.
Japan Times
WORLD / Science & Health
Jan 12, 2022
Biogen stung as U.S. limits coverage of Alzheimer’s therapy
Private insurers in the U.S. have mostly declined to cover Aduhelm, saying they need more proof of its efficacy and that benefits outweigh risks like brain swelling.
Japan Times
WORLD
Sep 3, 2021
Lawmakers probe ‘anomalies’ in approval of Biogen Alzheimer’s drug
The congressional inquiry adds to pressure on the U.S. agency charged with regulating products that account for one-fifth of consumer spending.
Japan Times
WORLD / Science & Health
Jul 29, 2021
Doctors blast Biogen Alzheimer approval as ‘regulatory failure’
The New England Journal of Medicine opinion piece is another sign of persistent furor over the agency's decision.
Japan Times
COMMENTARY / World
Jul 19, 2021
Latest U.S. Alzheimer's drug fix is a patch job
Most of the FDA's decisions don't receive national attention, which means they may not be rectified until substantial harm is done.
Japan Times
BUSINESS / Companies
Jul 13, 2021
Eisai pushes second Alzheimer's drug despite call to probe U.S. approval of first
The U.S. Food and Drug Administration's June approval of Aduhelm caused resignations among a panel of independent experts who said the therapy was ineffective.
Japan Times
COMMENTARY / World
Jun 14, 2021
Alzheimer’s drug furor highlights U.S. health system’s failures
The FDA didn't deny that the clinical-trial evidence was poor. It simply ignored that problem and used different reasoning to grant the drug 'accelerated approval.”
Japan Times
WORLD / Science & Health / ANALYSIS
Jun 11, 2021
U.S. FDA faces mounting criticism over Alzheimer's drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.
Japan Times
JAPAN / Science & Health
Jun 8, 2021
Changing the game for Alzheimer's treatment, U.S. approves Eisai and Biogen's drug
The approval appears to signal a fundamental shift in the way the FDA thinks about Alzheimer's disease, which could have lasting ramifications for other drugs in the pipeline.
Takaichi poised to become Japan's first female PM after winning LDP poll
Sanae Takaichi, the newly elected leader of the ruling Liberal Democratic Party, holds a news conference after the LDP presidential election in Tokyo on Saturday.
A Japanese ski resort town is roiled by a debate over immigration
A Swedish snowboard instructor works at the Niseko ski resort area on Hokkaido, in Kutchan, in December 2022
Tokyo's newest stationery store sells 'a slower, more human rhythm'
Plotter's signature customizable leather binder is just one of many products contributing to the ongoing boom in the popularity of Japanese stationery.
One dead, one missing in Japan after bear attack
A bear warning sign. More and more wild bears have been spotted in Japan in recent years, even in residential areas, due to factors including a declining human population and climate change.
Japan’s jobless rate edges up to highest in over a year
August’s unemployment figures showed a slight tempering of Japan's job market, but the data still points to overall firmness amid an ongoing labor shortage.
Eat your balloons: The culinary theater of Grant Achatz comes to Tokyo
Avant-garde chef Grant Achatz and his team from Alinea are in Tokyo for a three-week residency.
Japan’s first foreign wine investor plants its roots in Hokkaido
Intrigued by Japanese wines, Burgundy winemaker Etienne de Montille decided to explore Hokkaido's wine scene, eventually setting up his outpost in Hakodate in 2017.
Tea ceremony experts see matcha boom as a big opportunity
Atsuko Mori, founder and director of Kyoto-based tea salon Camellia Tea Ceremony, prepares matcha during a tea ceremony in Kyoto.
The summer kabuki came roaring back
Kabuki has been trying for years to attract a new generation of fans. One way to do this has been to adapt manga and anime franchises, such as “Naruto,” for the stage. 
How Ohtani has boosted Japan's soft power and made LA even more baseball-obsessed
Fans at Dodger Stadium pose in front of a mural highlighting the Dodgers' Japanese stars from past and present during a game earlier this year.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Growing families are being priced out of Tokyo’s condo market, forced to choose between downtown convenience and suburban space.
Is living in central Tokyo still affordable?
By Alex K.T. Martin

SUSTAINABLE JAPAN

We are pleased to announce the winners of the 6th annual Sustainable Japan Award.
We are pleased to announce the winners of the 6th annual Sustainable Japan Award.

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER